T‐type calcium channels as therapeutic targets in essential tremor and Parkinson's disease

por Matthews, Lillian G., Puryear, Corey B., Correia, Susana S., Srinivasan, Sharan, Belfort, Gabriel M., Pan, Ming‐Kai, Kuo, Sheng‐Han
Publicado 2023

Translational Pharmacology of PRAX‐944, a Novel T‐Type Calcium Channel Blocker in Development for the Treatment of Essential Tremor

por Scott, Liam, Puryear, Corey B., Belfort, Gabriel M., Raines, Shane, Hughes, Zoë A., Matthews, Lillian G., Ravina, Bernard, Wittmann, Marion
Publicado 2022

High-Performance Genetically Targetable Optical Neural Silencing via Light-Driven Proton Pumps

por Chow, Brian Y., Han, Xue, Dobry, Allison S., Qian, Xiaofeng, Chuong, Amy S., Li, Mingjie, Henninger, Michael A., Belfort, Gabriel M., Lin, Yingxi, Monahan, Patrick E., Boyden, Edward S.
Publicado 2010

Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(A) receptor positive allosteric modulator

por Althaus, Alison L., Ackley, Michael A., Belfort, Gabriel M., Gee, Steven M., Dai, Jing, Nguyen, David P., Kazdoba, Tatiana M., Modgil, Amit, Davies, Paul A., Moss, Stephen J., Salituro, Francesco G., Hoffmann, Ethan, Hammond, Rebecca S., Robichaud, Albert J., Quirk, Michael C., Doherty, James J.
Publicado 2020